Klox Technologies IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on Klox Technologies, and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Klox Technologies | KLOX - NASDAQ |
$13.00-$15.00 |
$0.00 |
$0.00 | 4.8 million | |
UBS Investment Bank |
Co-Manager(s): Canaccord Genuity, Needham & Company, National Bank of Canada Financial Inc. |
|
Filing(s): Filed 2015-02-11 Terms Added 2015-04-27
|
About Klox Technologies (adapted from Klox Technologies prospectus):
They are a specialty pharmaceutical company focused on developing and commercializing products based on our proprietary BioPhotonic technology platform to address skin and soft tissue disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "KLOX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved